N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 14.82 CNY -0.74%
Market Cap: 23.9B CNY
Have any thoughts about
Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-56.5
Current
23.8
Median
13.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-56.5
=
Enterprise Value
24.4B CNY
/
EBITDA
-432.3m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
17.8
2-Years Forward
EV/EBITDA
13.5
3-Years Forward
EV/EBITDA
10.7

See Also

Discover More